AngioGenex, Inc. — Form D
AngioGenex, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2021-12-17. The offering totals $260K, of which $260K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2021-12-17
- Form: D
- Accession: 0001469709-21-000077
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $260K
- Amount sold: $260K
- Investors: 1
- Date of first sale: 2021-12-17
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-425689
Issuer
- Name: AngioGenex, Inc.
- CIK: 0001085596
- Entity type: Corporation
- Jurisdiction: NEVADA
- Address: 425 MADISON AVENUE, SUITE 902, NEW YORK, NY, 10017
- Phone: 646-642-0701
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Michael Aronstein | Director | New York, NY |
| Martin Murray | Director | New York, NY |
| Michael Strage | Director | New York, NY |
| Michael Aronstein | Executive Officer | New York, NY |
| Martin Murray | Executive Officer | New York, NY |
| Michael Strage | Executive Officer | New York, NY |
| Richard Salvador | Director | New York, NY |
| Richard Salvador | Executive Officer | New York, NY |
| William Garland | Director | New York, NY |
| William Garland | Executive Officer | New York, NY |
Other filings by this issuer (1)
More